HIGHLIGHTS
- who: Hajra Ashraf and collaborators from the Department of Biomedical Sciences, University of Sassari, Sassari, Italy have published the article: Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases, in the Journal: Pharmaceuticals 2022, 15, 1077. of /2022/
- what: The authors aimed to provide a critical overview of recent data on pharmacotherapies used to treat autoimmune neurological diseases and to highlight the recent advances in drug development for neurological diseases. Currently, the major focus of MS treatments 3 of 26 is to avert inflammations in the central nervous system (CNS). Through . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.